Cell Injury Cell Death: January 3 & 5, 2006 Nelson Fausto, M.D
Cell Injury Cell Death: January 3 & 5, 2006 Nelson Fausto, M.D
Cell Injury Cell Death: January 3 & 5, 2006 Nelson Fausto, M.D
The syllabus for Cell Injury and Cell Death covers the material to be presented at the lectures on this topic (Jan. 3-5). The textbook reading for these lectures is Chapter 1 of Robbins and Cotran, 7th edition. Alcohol abuse coverage is Chapter 9, p421-424. The presentation of material in the syllabus and lectures may not follow the exact order of presentation of the material in the textbook. Nevertheless, there are no conflicts in concepts between the syllabus and textbook. The information is easy to locate in Robbins. As you study the material, use the lecture presentations and the syllabus as a guide for what to emphasize. The material presented in the syllabus and lectures is, however, required knowledge. The most important goal is to gain a general understanding of cellular adaptations, cell injury and the two types of cell death, known as necrosis and apoptosis.
I will not cover in the lectures or syllabus some of the topics presented in the textbook. For these topics, I expect you to know the meaning of some terms (this includes heterophagy/autophagy, cytoskeletal abnormalities, intracellular accumulations of cholesterol, protein, glycogen, pigments and calcification). You should be able to define and recognize these types of injury. I also suggest that you take a look at Chapter 3 p90-94, to become familiar with tissue homeostasis, stem cells and cloning. The study of cell injury and cell death is the basis for the understanding of disease mechanisms. It is interesting and essential material for medical practice and medical science. I hope that you will enjoy studying these topics, as I do teaching this material, which is both basic science and clinical medicine. At the end of the syllabus (Appendix 1) you will find some clinically relevant questions related to the lectures. Nelson Fausto, M.D.
"One can be fooled by appearances, which happens only too frequently, whether one uses a microscope or not" (Voltaire) "...can the human soul be glimpsed through a microscope? May be, but you'd definitely need one of those very good ones with two eyepieces" (Woody Allen) 1
1. Pathology
Study of disease process as to: 1. Causes (etiology) 2. Mechanisms of development (pathogenesis) 3. Structural and functional alterations (consequences and clinical significance)
have been identified in at least 2 areas of mammalian brain. It is not known if these cells may contribute to brain remodeling and regeneration.
cell survives
stimulus persists
failure of adaptation
hostile environment
stimulus persists increased cellular activity metabolic induction increase in cell size increase in cell number (hypertroph
stimulus persists decreased cellular activity metabolic decline decrease in cell size decrease in cell number (atrophy)
Change in number of cells Hyperplasia Atrophy Increase in the number of cells Decrease in the number of cells
10. General principles regarding cellular response to injury and its consequences.
1. 2. 3. 4. Response depends on nature of injury, duration and severity. Consequences of injury depend on cell type. Morphologic changes detectable by light microscopy may occur much later than functional lesion. Although different agents may have different initial cellular targets, the final pathways are often similar.
free cytosolic Ca
++
activation of ATPases
activation of phospholipases
activation of proteases
activation of endonucleases
decreased ATP
membrane damage
cytoskeletal disassembly
chromatin damage
generation of free radicals by redox reactions xanthine oxidase free iron neutrophils oxygen therapy drugs/toxins irradiation reperfusion injury
depletion of free radical scavengers (vitamins E, C, and A) and other antioxidant defenses, such as glutathione, glutathione peroxidase/reductase, superoxide dismutase and catalase
damaging effects on cell peroxidation of lipids damage of thiol-containing protein mitochondrial damage DNA damage
membrane damage membrane damage apoptosis, decreased respiration apoptosis; carcinogenesis (long term)
10
excess ROS, increased cytosolic Ca.. Damage to lysosome membrane causes release of enzymes into the cytoplasm and digestion of cellular components
Coagulation necrosis (typical necrosis after myocardium infarct) Liquefaction necrosis (necrosis involving tissue digestion; common in the brain) Fat necrosis (necrosis involving release of enzymes in tissues containing or surrounded by fat cells,
such as the pancreas) Caseous necrosis (typical of tuberculosis) Gangrene (dry gangrene; ischemic injury in fingers, toes) .
11
changes leading to mild cellular swelling. Prolonged ischemia causes irreversible damage to cell membranes causing cell death.
mitochondrial swelling
failure of membrane NaK ATPase pump influx of Na+ and water; efflux of K+ swelling of endoplamic reticulum
failure of membrane calcium pumps free calcium enters cytoplasm activation of phospholipases
switch to anaerobic metabolism depletion of glycogen and increased lactic acid fall in intracellular pH
12
[Other examples of proteins released into the blood in tissue necrosis ischemic or otherwise: Exocrine pancreas, amylase; striated muscle, creatine kinase (MM isoform); liver damage, alanine aminotransferase (ALT) and aspartate aminotransferase (AST).]
13
prominently in the liver. Examples of indirect acting drugs are carbon tetrachloride and acetaminophen (known as paracetamol and commonly referred to as Tylenol).
Antibiotics (amphotericin B, etc.) Metals (mercury, cadmium, bismuth, etc.) Solvents (ethylene glycol, etc.) Iodinated contrast agents Anti-neoplastic agents (cisplatin, etc.)
}
Eucalyptol
Glutethimide Griseofulvin Halogenated insecticides (primarily lindane and DDT) Halothane Heptobarbital Meprobamate Phenobarbital Phenylbutazone Phetharbital 14
CCl4
cytochrome p450
CCl 3
lipid peroxidation
ER damage
apoprotein synthesis
fatty liver
NECROSIS
15
28.
Apoptosis
This form of cell death is also known as programmed cell death because it requires the activation of signal transduction pathways and proteases that initiate and execute the process of cell death. Apoptosis can be physiological or pathological and often results in the elimination of abnormal or unwanted cells (it is as if these cells commit suicide by eliminating themselves through the activation of the apoptotic machinery). Physiological apoptosis Destruction of cells during embryonic development 16
Balance between cell death/proliferation in normal tissues Regulation of cellular populations in hormonally sensitive tissues
Pathological apoptosis Cell death after DNA damage caused by radiation, cancer treatment drugs Cell death caused by cytotoxic T cells; death of B and T lymphocytes Cell death caused by many viruses Cell death in tumors, in growing tumor but particularly during tumor regression Cell death in reperfusion injury
Non-receptor mediated: Radiation, ROS release, toxins, chemotherapeutic agents, among others
(Mitochondrial Pathway) In receptor-mediated apoptosis, the process is initiated by the binding of the ligand to its receptor in the cell membrane. TNF binds to its type 1 receptor (TNFR1) while the Fas ligand binds to Fas. Both receptors have sequences called death effector protein domains that serve as docking sites for binding adapter proteins such as FADD (Fas-associated protein with death domain) and TRADD (TNFR adapter protein with death domain). In non-receptor mediated apoptosis, caspases (see below) are activated without the binding of a ligand to receptors. Depending on the agent and the cell type, apoptosis is highly dependent on mitochondrial damage. Particularly important is the loss of mitochondrial membrane permeability, creating a a high-conductance channel that causes the release of cytochrome c into the cytoplasm. Cytochrome c can initiate the cleavage of pro-caspases into active caspases.
The adapter proteins bound to death-domain receptor, or the release of proaptotic molecules such as cytochrome c through the mitochondria pathway, trigger the activation of caspases (cysteine proteases that cleave proteins at aspartic acid residues). There are many different caspases, which are present in the cell in inactive, precursor forms (pro-caspases). Some of these caspases (caspases 8 and 9) initiate the process(initiator caspases) while others, such as (caspase 3), deliver the final blow, and are known as executioner caspases).
18
19
HEPATOCYTE SMOOTH ENDOPLASMIC RETICULUM CYTOSOL Alcohol dehydrogenase Microsomal ethanol oxidizing system
- 2H NAD NADH
Increased function of drug metabolizing systems Increased: Smooth endoplasmic reticulum P450 Drug metabolism Increased activation of: Hepatotoxins
NADPH NADP
Acetaldehyde Aldehyde dehydrogenase Mitochondria Cytosol Covalent binding to proteins: ROS release, membrane peroxidation -2H
FAT Accumulation Fatty acid oxidation Fatty acid synthesis and esterification
NAD NADH
Acetate
20
37. Metabolism through smooth endoplasmic reticulum P450 oxidizing system (MEOS = microsomal ethanol oxidizing system)
Microsomal induction explains the increased susceptibility of alcoholics to toxicity of other compounds metabolized to active by-products in the smooth endoplasmic reticulum - industrial solvents (carbon tetrachloride, bromobenzene), drugs (anesthetics, izoniazid, phenylbutazone, acetaminophen), carcinogens (aflatoxin, nitrosodimethylamine), and other toxic agents (cocaine). Similarly, drug catabolism may be accelerated in chronic alcoholics reducing the efficacy of these agents (coumadin, tolbutabmide, propranol, rifampin). In contrast, acute use of alcohol inhibits drug catabolism thereby potentiating the effects of tranquilizers and barbiturates. 21
38. Drug alcohol interaction: chronic ethanol ingestion leads to increased metabolism of many drugs
Increased activity of the mixed function oxidase system (MFOS) is associated with increased rates of drug metabolism by the microsomal cell fraction in vitro and by increased rates of drug clearance in vivo. In man chronic ethanol ingestion has been found to increase rates of metabolism of pentobarbital, antipyrine, tolbutamide, warfarin, and meprobamate, the latter shown on this slide. The increased rates of drug clearance in vivo relate to ethanol-induced increases in the MFOS and perhaps to other factors, such as increased liver blood flow and increased supply of NADPH produced by ethanol.
39. Drug alcohol interaction: Decreased drug metabolism after acute alcohol
Drug metabolism in alcoholics is complex. For example, an acute large dose of ethanol may decrease the rate of metabolism of some drugs, as shown here. Therefore, the chronic heavy user of ethanol, also accustomed to using large amounts of sedatives, may inadvertently take a fatal overdose if the same amount of drug is ingested with a large dose of ethanol.
22
Furthermore, levels of cytochrome P-450 and activities of MFOS fall in actively inflamed or cirrhotic livers. If chronic heavy use of ethanol produces serious liver injury, tolerance to drugs, once enhanced by ethanol, may progressively decline. Note: The effects of alcohol/drug interactions result in more rapid or slower drug metabolism. The biological effect produced by these interactions depends on whether the metabolism of the drug leads to detoxification or activation.
41. Fatty liver reversible liver injury; intracellular accumulation of fat in hepatocytes causes liver
enlargement with no clinical symptoms. There are several biochemical mechanisms responsible for fat accumulation induced by alcohol (see diagram, next page). The most important factor is decreased oxidation of fatty acids:
42. Alcoholic hepatitis and fibrosis potentially reversible liver injury; localized cell death of hepatocytes; intracellular accumulation of fat and alcoholic hyalin around central veins (Mallory bodies) in hepatocytes. Neutrophils around foci of necrosis. Symptoms - fever, liver tenderness, jaundice.
There are several suspected mechanisms responsible for hepatocyte necrosis (nutritional deficiency has been eliminated as a cause): mitochondrial injury, toxicity due to acetaldehyde (protein cross-linking, and formation of
23
free radicals). Hepatocyte cell death might occur through an immune mediated mechanism which activates the FAS apoptotic pathway.
43. Alcoholic cirrhosis a stage of irreversible liver damage, generally in the form of micronodular cirrhosis
(fibrosis between small regenerating nodules of hepatocytes) generally with fatty change. This is a serious disease accompanied by muscle wasting, weakness, ascites, and a tendency for massive gastrointestinal hemorrhage (esophageal varices). Fibrosis may develop starting around central veins. The mechanisms responsible for the fibrous scarring of cirrhosis are not well known. The earliest lesions begin around the central vein. This is followed by perisinusoidal fibrosis, perhaps due to the activation of stellate cells (mesenchymal cells located in the space of Disse). These cells are the major source of collagen in liver fibrosis and cirrhosis.
24
25
26
27